By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Micronics today said that it has received a $2.6 million from the US Department of Defense to support development of its PanNAT system for point-of-care molecular diagnostics of infectious pathogens.

Redmond, Wash.-based Micronics is developing the sample-to-answer system for rapid disease detection. It said that the PanNAT system will directly detect multiple blood-borne pathogens, including hepatitis B and C and HIV, in fresh blood samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.